Thus, breast cancer cells have developed effective strategies for circumventing the tumor suppressing activities of TGF-β, while simultaneously selecting for, or even enhancing, its tumor promoting activities [8,17]. The gene discussed is TGFB1; the disease is breast carcinoma.